Literature DB >> 6134980

Studies of cellular immunity in male homosexuals in London.

A J Pinching, T J McManus, D J Jeffries, O Moshtael, M Donaghy, J M Parkin, P E Munday, J R Harris.   

Abstract

97 symptom-free homosexuals were studied clinically, serologically, and with in-vivo and in-vitro tests of cellular immune function in the context of the acquired immunodeficiency syndrome (AIDS). A high proportion of these men showed abnormalities: lymphopenia (33%), decreased T-helper/T-suppressor (Th/Ts) cell ratios (43%), both these abnormalities (12%), decreased total T-helper cells (15%), monocyte chemotactic (10%) and phagocytic (27%) defects, anergy to three recall antigens (32%), and anergy to purified protein derivative despite BCG inoculation (55%). The lymphocyte abnormalities and anergy characteristic of AIDS were seen in 5%. No clear clinical or serological associations were seen for the AIDS-like defects. Trends of association were seen between higher lymphocyte counts, lower Th/Ts ratios, more T-suppressor cells and serological evidence of previous virus infection. The combination of lymphocyte abnormalities and anergy observed in these symptom-free homosexuals may represent a latent phase of AIDS.

Entities:  

Mesh:

Year:  1983        PMID: 6134980     DOI: 10.1016/s0140-6736(83)90115-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  Abnormality of Leu 2+7+ cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals.

Authors:  S Gupta
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

2.  Herpes zoster and the stage and prognosis of HIV-1 infection.

Authors:  A McNulty; Y Li; U Radtke; J Kaldor; R Rohrsheim; D A Cooper; B Donovan
Journal:  Genitourin Med       Date:  1997-12

3.  Increase in dendritic cell numbers, their function and the proportion uninfected during AZT therapy.

Authors:  M Gompels; S Patterson; M S Roberts; S E Macatonia; A J Pinching; S C Knight
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

4.  Immune functions in homosexual men with antibodies to HTLV-III in Finland.

Authors:  K Krohn; A Ranki; J Antonen; S L Valle; J Suni; A Vaheri; C Saxinger; R C Gallo
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

5.  Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.

Authors:  G Poli; B Bottazzi; R Acero; L Bersani; V Rossi; M Introna; A Lazzarin; M Galli; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

6.  Abnormal antibody responses in patients with persistent generalized lymphadenopathy.

Authors:  H D Ochs; A K Junker; A C Collier; F S Virant; H H Handsfield; R J Wedgwood
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

7.  Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts.

Authors:  E Fernandez-Cruz; A M Fernandez; C Gutierrez; M Garcia-Montes; M T de la Morena; J Rodriguez-Villanueva; N Longo; J M Zabay
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

8.  Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia.

Authors:  V L Krishnan; A Meager; D M Mitchell; A J Pinching
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

9.  Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome.

Authors:  A Lazzarin; C Uberti Foppa; M Galli; A Mantovani; G Poli; F Franzetti; R Nóvati
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

10.  Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome.

Authors:  G M Shearer; S M Payne; L J Joseph; W E Biddison
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.